Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RHINITIS MEDICAMENTOSA

Known as: RHINITIS MEDICAMENTOUS 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
We aimed to determine the presence of oxidative stress in rhinitis medicamentosa (RM) and to evaluate the effect of erdosteine… Expand
Is this relevant?
2012
2012
The aim is to present a patient with severe bilateral corneal complications after long-term antiglaucoma treatment with 1… Expand
Is this relevant?
2008
2008
Background The purpose of this study was to evaluate long-term outcomes of an outpatient-based diode laser inferior turbinate… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2007
2007
OBJECTIVE: Prolonged application of nasal vasoconstrictors causes rhinitis medicamentosa (RM). Nasal obstruction is induced by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
Review
2006
Review
2006
Rhinitis medicamentosa (RM) is a condition induced by overuse of nasal decongestants. The term RM, also called rebound or… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2005
Review
2005
  • Peter Graf
  • Treatments in respiratory medicine
  • 2005
  • Corpus ID: 25175067
Rhinitis medicamentosa (RM) is a drug-induced, nonallergic form of rhinitis that is associated with prolonged use of topical… Expand
Is this relevant?
2004
2004
To evaluate the nasal mucosal changes in rhinitis medicamentosa (RM), especially those related to goblet cells and subepithelial… Expand
  • table 1
  • figure 2
  • table 2
  • figure 3
  • figure 4
Is this relevant?
Review
1999
Review
1999
  • Peter Graf
  • Clinical therapeutics
  • 1999
  • Corpus ID: 23085385
Prolonged, repeated use of nasal decongestants for symptomatic relief of allergic rhinitis often results in rhinitis… Expand
Is this relevant?
Review
1997
Review
1997
With modern vasoconstrictors, such as oxy- and xylometazoline, the risk of developing rhinitis medicamentosa (RM) has been… Expand
Is this relevant?
1997
1997
With modern vasoconstrictors, such as oxy- and xylometazoline, the risk of developing rhinitis medicamentosa (RM) has been… Expand
Is this relevant?